Covaxin Recommended For Next Phase Of Trials For 2-18 Age Group: Report | Read
PUBLISHED ON: May 12, 2021 | Duration: 3 min, 04 sec
Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase-2 and phase-3 clinical trials on those aged between two to 18 years, official sources said.
